Abstract:Objective Nitroglycerin (NTG)and other nitrovasodilators have been widely used to treat congenital heart disease,primary cardiomyopathy and congestive heart failure in pediatrics. However,during the long\|term administration,the hemodynamic and anti\|ischemic efficacy of NTG is rapidly attenuated by the development of tolerance.This study aimed at investigating whether angiotensin Ⅱreceptor antagonist losartan could improve NTG tolerance in vivo. Methods Losartan potassium was purchased from Trademark of EI,Du Pont de Nemours and Company,Delaware,USA.Endothelin I (ET\|I) radioimmunoassay reagent was purchased from Phoenix Pharmaceuticals Inc. NTG patch (16 mg/patch) was purchased from Zhuhai Schwarz Pharma Company Limited. Trasylol was made by Bayer AG, Germany UK Subsidiary.Male Wistar rats weighing 250\|300 g were provided by Experimental Animal Center of Peking University. A total of 28 rats were divided into 4 groups.(1) Control group( n =10):No drugs were used.(2)NTG group( n =6):NTG tolerance animal model was prepared according to Munzel T and Urmlia, et al. A region between scapulae was shaved and NTG patch (0.05mg/h)was applied to the skin. The treatment period started between 8 AM and 10 AM and NTG patch was changed each morning for the ensuing 2 days. (3)losartan group( n =6):losartan 10 mg/(kg·d) was given by gavage for 2 days. (4)NTG plus losartan group( n =6):losartan 10 mg/(kg·d) was given by gavage for 2 days and simultaneously NTG patch treatment was given the same as NTG group. Results Hypotensive responses in the 4 groups before sodium nitroprusside (SNP) showed no significant difference. Hypotensive responses after SNP 20 ug/kg, iv were different among 4 groups. The percentage of hypotensive response to SNP was decreased in NTG group(21±4)% compared with that in control group(34±4)%, P 0.01. The hypotensive response was enhanced in NTG plus losartan group (31±5)% compared with that in NTG group, P 0.01.The maximal vessel relaxation induced by SNP was the same in 4 different groups but the highest EC 50 (concentration which produces 50% of the maximal response to SNP) was found in NTG group [(33.89±10.86)nmol/l, P 0.01].The ET\|1 amounts in plasma and vascular tissue were markedly increased by 54% and 60% in NTG group compared with those in control group ( P 0.01).In contrast to NTG proup the ET\|1 amounts in plasma and vascular tissue were decreased by 30% and 37% in NTG plus losartan group ( P 0.01).Conclusion The results of the study supported that angiotensin Ⅱ receptor antagonist losartan seemed to be a possible candidate medicine to prevent from NTG tolerance in vivo.

Effect of Metallothionein on Tolerance of Nitroglycerin in Rats

EFFECT OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND ENDOTHELIN RECEPTOR ANTAGONIST ON NITROGLYCERIN TOLERANCE IN RATS

Efficacy of Different Doses of Nitroglycerin Combined with Clopidogrel in the Treatment of Angina Pectoris

Metabonomic Studies on Intact Livers and Liver Extracts from Rats Treated with Neodymium Nitrate

The Effect of Losartan Treatment on Nitroglycerin Tolerance in Rats

Prevention of Nitroglycerin Tolerance in Vitro by T0156, a Selective Phosphodiesterase Type 5 Inhibitor

Identification of the Enzymatic Mechanism of Nitroglycerin Bioactivation.

Decreased PKG transcription mediated by PI3K/Akt/FoxO1 pathway is involved in the development of nitroglycerin tolerance.

Progress in tolerance of nitrate

Prevention of myocardial fibrosis by using nitrendipine to the spontaneously hypertensive rats

Protective effects of Zn-induced metallothionein on myocardial injury of hypertensive rats

Decreased PKG Transcription Mediated by PI3K/Akt/FoxO1 Pathway is Involved in the Development of Nitroglycerin Tolerance

Long-term inorganic nitrate administration protects against myocardial ischemia-reperfusion injury in female rats

Preclinical study for the ameliorating effect of l-ascorbic acid for the oxidative stress of chronic administration of organic nitrates on myocardial tissue in high sucrose/fat rat model

Elucidation of the Role of L-Arginine and Nω-Nitro-L-Arginine in the Treatment of Rats with Different Levels of Hypoxic Tolerance and Exposure to Lead Nitrate

Head-to-head comparison of inorganic nitrate and metformin in a mouse model of cardiometabolic disease

Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension

Protective effect of dietary nitrate on experimental gastritis in rats

Cardiac-specific overexpression of metallothionein attenuates L-NAME-induced myocardial contractile anomalies and apoptosis

N-004 INORGANIC NITRITE ATTENUATES ANGIOTENSIN II INDUCED CONTRACTION OF THE RENAL MICROCIRCULATION VIA XANTHINE OXIDASE-DEPENDENT NO PRODUCTION

Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME